Search

User Login

Our Best Deals

282,00 € each Sculptra
2.500,00 € each Herceptin 440 MG Vial
1.000,00 € each Mabthera 500mg
273,00 € each Juvederm Ultra 4
1.140,00 € each ALIMTA 500MG VIAL
130,00 € each Restylane 1ml

Actilyse 50mg vial

920,00 € each

+

Actilyse is a medicine which is used in ischaemic stroke, pulmonary embolism and treatment of myocardial infarction. Actilyse contains alteplase.

Myocardial infarction: Alteplase is given intravenously as thrombolytic therapy to patients with suspected occlusive coronary artery thrombi. Alteplase should be given as soon as possible or within 12 hours of symptom onset. Pulmonary embolism: Alteplase is given as thrombolytic therapy in patients with acute massive pulmonary embolism. Acute ischaemic stroke: Alteplase is given as thrombolytic in the treatment of acute ischaemic stroke. Alteplase should be started within three hours after the onset of stroke symptoms only after intracranial haemorrhage has been excluded by CT.

Action of Actilyse 50 mg:
Actilyse is an enzyme that increases another enzyme, plasmin, which is important in breaking down clots in the blood stream. This is useful in some patients following a heart attack, pulmonary embolism (blood clot in the lungs) or a stroke.

Related products

Results 1 - 1 of 1
1.600,00 € each Tarceva 150mg Tablets
Results 1 - 1 of 1

About us

Welcome to Prestige Fillers the longest standing, and the most trusted supplier of dermal fillers in Europe.

Prestige Fillers has genuinely developed and strengthened close relationships in the medical supply industry just to ensure that we can accommodate any and all of your needs for medical professionals on an international level! We have dedicated our time and resources to providing the safest and most private way to buy medical products online at wholesale prices from licensed sources. We provide more than just competitive pricing...Read More

Contact us

1. UNITED STATES

Phoenix, Arizona, U.S.A

2. EUROPE

Odessa, Ukraine

 Customer Service:

Tel/Fax. +1 520 422 4341

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.